[2]
Anand, K.; Wakode, S. Development of drugs based on Benzimidazole Heterocycle: Recent advancement and insights. Int. J. Chem. Stud., 2017, 5, 350-362.
[32]
Hasler, W.; Ji, Y.; Leupin, W. Antibacterial dibenzimidazole derivatives US5824698, 1998, . 106
[70]
Küçükbay, H.; Yilmaz, Ü.; Şireci, N.; Güvenç, A.N. Synthesis and antimicrobial activities of some bridged bis-benzimidazole derivatives. Turk. J. Chem., 2011, 35, 561-571.
[84]
Leoni, L.M. In in Bendamustine: Rescue of an effective antineoplastic agent from the mid-twentieth century; Seminars in Hematology; Elsevier, 2011, Vol. 48, pp. S4-S11.
[85]
Shrivastava, N.; Naim, M.J.; Alam, M.J.; Nawaz, F.; Ahmed, S.; Alam, O. Benzimidazole scaffold as anticancer agent: Synthetic approaches
and structure–activity relationship. Arch. Pharm., (Weinheim), 2017, 350, e201700040..
[96]
Ferrington, D.A.; Gregerson, D.S. Immunoproteasomes: structure, function, and antigen presentation. Prog. Mol. Biol. Transl. Sci., 2012, 109, 75-112.
[108]
Jones, P.A.; Buckley, J.D. The role of DNA methylation in cancer.Advances in cancer research; Elsevier, 1990, Vol. 54, pp. 1-23.
[112]
Darii, M.; Rakhimova, A.; Tashlitsky, V.; Kostyuk, S.; Veiko, N.; Ivanov, A.; Zhuze, A.; Gromova, E. Dimeric bisbenzimidazoles:
Cytotoxicity and effects on DNA methylation in normal and cancer
human cells. Mol. Biol., (N. Y.), 2013, 47, 259-266.
[121]
Martinez, A.J. Free-living amoebas; natural history, prevention, diagnosis, pathology and treatment of disease; CRC Press, 1985, p. 156.
[124]
Visvesvara, G.S. Free-living amoebae as opportunistic agents of human disease. J. Neuroparasitology, 2010, 1, 100802
[126]
Visvesvara, G.S. Infections with free-living amebae.Handbook of clinical neurology; Elsevier, 2013, Vol. 114, pp. 153-168.
[142]
Korolev, S.; Tashlitsky, V.; Smolov, M.; Gromyko, A.; Zhuze, A.; Agapkina, Y.Y.; Gottikh, M. HIV-1 integrase inhibition by dimeric
bisbenzimidazoles with different spacer structures. Mol. Biol., (N.Y
), 2010, 44, 633-641.
[148]
Sessler, J.L.; Gale, P.A.; Cho, W. Anion receptor chemistry; Royal Society of Chemistry, 2006, Vol. 8, .
[149]
Ponticorvo, L.; Rittenberg, D.; Bloch, K. The utilization of acetate for the synthesis of fatty acids, cholesterol, and protoporphyrin. J. Biol. Chem., 1949, 179, 830-842.
[151]
Frenkel, G.; Nelson, D.L.; Soltvedt, B.C.; Lehninger, A.L. Test Bank for Nelson and Cox, Lehninger Principles of Biochemistry; Worth Publishers, 2000.
[153]
Gupta, C. Role of iron (Fe) in body. IOSR J. Appl. Chem. (IOSRJAC), 2014, 7, 38-46.
[154]
Kühn, L. In Control of cellular iron transport and storage at the molecular level; Iron nutrition in health and disease; John Libbey & Company, 1996, pp. 17-29.
[202]
Mikhailov, M.V.; Zasedatelev, A.S.; Krylov, A.S.; Gurskii, G.V. Mechanism of AT base pairs recognition by molecules of dye
"Hoechst 33258". Mol. Biol., (Mosk), 1981, 15, 690-705.